Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Investing

Lloyds Pharmacy to close all 237 Sainsbury’s outlets

by
January 20, 2023
in Investing
0
Lloyds Pharmacy to close all 237 Sainsbury’s outlets
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Lloyds Pharmacy is closing all 237 of its outlets in Sainsbury’s supermarkets amid fears of insufficient government funding for the industry.

The group said it was making the closures – which are thought to affect about 2,000 jobs – “in response to changing market conditions”, adding it was “currently exploring options for each individual branch”.

Kevin Birch, the chief executive of Lloyds, said: “This decision has not been an easy one and we understand that our patients and customers may have questions about how the change will affect them. We would like to thank them for their continued support and assure them that we are committed to providing a smooth transition over the coming months.”

The company did not confirm the number of jobs affected. It told the trade journal Chemist+Druggist: “Lloyds Pharmacy is committed to helping patients easily find a suitable alternative provision.”

Sainsbury’s confirmed that the closures would take place over the coming months and said it would “work with [Lloyds] to ensure customers are clear on how they can access an alternative pharmacy provision to meet their needs”.

The closures come about seven years after the supermarket sold its then 281-store pharmacy business to Celesio, the owner of Lloyds Pharmacy, for £125m. The pharmacy chain was bought last year by the investment firm Aurelius, which also recently acquired the sports fashion retailer Footasylum.

While health and beauty sales are thought to remain strong, pharmacies, like other retailers, have faced rising costs and difficulties in finding staff.

Nigel Swift, the deputy managing director of Phoenix UK, which owns the Numark and Rowlands pharmacy groups, said the Lloyds closures had to be a wake-up call for the government.

He said: “This announcement is the clearest possible sign of the dire situation facing community pharmacy in England as a result of insufficient government funding. Since the start of the pharmacy contract there has been a massive cut in real-term funding, resulting in hundreds of closures.

“At a time when the NHS is in crisis, the community pharmacy network is needed more than ever before. These closures will put even more pressure on already overstretched nearby pharmacies and dilute patient access to essential healthcare services, particularly in deprived communities.”

A spokesperson for the Department of Health and Social Care said: “Community pharmacies play a vital role in our healthcare system and we back them with £2.6bn a year. On top of this, we have announced a further £100m investment in the sector to help support services.”

They added that about 80% of people live within 20 minutes of a community pharmacy.

Read more:
Lloyds Pharmacy to close all 237 Sainsbury’s outlets

Previous Post

Millionaires are falling out of love with Britain

Next Post

Plastic bottle deposit return scheme looks set to launch in England

Next Post
Plastic bottle deposit return scheme looks set to launch in England

Plastic bottle deposit return scheme looks set to launch in England

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

That Bangladesh Mask Study!

December 1, 2021

Antitrust Regulation Assumes Bureaucrats Know the “Correct” Amount of Competition

November 24, 2021
Pints of champagne could be the next ‘Brexit dividend’

Pints of champagne could be the next ‘Brexit dividend’

December 24, 2021

Mitolyn Review 2025: Best Way to Support Healthy Weight Loss

0

0

0

0

Mitolyn Review 2025: Best Way to Support Healthy Weight Loss

August 6, 2025

“From Cancer to Compassion: The Inspiring Journey of a Toronto Doctor – A Memoir”

August 5, 2025
One in Five ICE Arrests Are Latinos on the Streets with No Criminal Past or Removal Order

One in Five ICE Arrests Are Latinos on the Streets with No Criminal Past or Removal Order

August 5, 2025

The Complexity of Historical Narratives

August 5, 2025

Recent News

Mitolyn Review 2025: Best Way to Support Healthy Weight Loss

August 6, 2025

“From Cancer to Compassion: The Inspiring Journey of a Toronto Doctor – A Memoir”

August 5, 2025
One in Five ICE Arrests Are Latinos on the Streets with No Criminal Past or Removal Order

One in Five ICE Arrests Are Latinos on the Streets with No Criminal Past or Removal Order

August 5, 2025

The Complexity of Historical Narratives

August 5, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.